Thymic lymphoma induction by the AKT8 murine retrovirus.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

30 citing papers in PubMed, 99 citations in OpenAlex.

1. PI3K/AKT signaling in parasites and parasite diseases: Role and therapeutic potential.Virulence · 2025
   Review
2. PI3K/Akt signaling transduction pathway, erythropoiesis and glycolysis in hypoxia (Review).Molecular medicine reports · 2019
   Review
3. Murine Endogenous Retroviruses Are Detectable in Patient-Derived Xenografts but Not in Patient-Individual Cell Lines of Human Colorectal Cancer.Frontiers in microbiology · 2018
   Article
4. Presence of a Shared 5'-Leader Sequence in Ancestral Human and Mammalian Retroviruses and Its Transduction into Feline Leukemia Virus.Journal of virology · 2017
   Article
5. PI3K/AKT Pathway and Its Mediators in Thyroid Carcinomas.Molecular diagnosis & therapy · 2016
   Review
6. Phosphoinositides: Key modulators of energy metabolism.Biochimica et biophysica acta · 2015
   Review
7. Targeting oncogenic ALK and MET: a promising therapeutic strategy for glioblastoma.Metabolic brain disease · 2013
   Review
8. Ex vivo γ-retroviral gene therapy of dogs with X-linked severe combined immunodeficiency and the development of a thymic T cell lymphoma.Veterinary immunology and immunopathology · 2011
   Article
9. Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway.Leukemia · 2011
   Review
10. Myocardial AKT: the omnipresent nexus.Physiological reviews · 2011
    Review
11. Targeting signal transduction pathways to eliminate chemotherapeutic drug resistance and cancer stem cells.Advances in enzyme regulation · 2010
    Review
12. Akt2 regulation of Cdc2-like kinases (Clk/Sty), serine/arginine-rich (SR) protein phosphorylation, and insulin-induced alternative splicing of PKCbetaII messenger ribonucleic acid.Endocrinology · 2009
    Article
13. Non-peptidic substrate-mimetic inhibitors of Akt as potential anti-cancer agents.Bioorganic & medicinal chemistry · 2009
    Article
14. The transforming mutation E17K/AKT1 is not a major event in B-cell-derived lymphoid leukaemias.British journal of cancer · 2008
    Article
15. Targeting prostate cancer based on signal transduction and cell cycle pathways.Cell cycle (Georgetown, Tex.) · 2008
    Review
16. Modulation of nuclear factor-ϰB by human T cell leukemia virus type 1 tax protein : Implications for oncogenesis and inflammation.Immunologic research · 2006
    Article
17. Inhibition of protein synthesis by Y box-binding protein 1 blocks oncogenic cell transformation.Molecular and cellular biology · 2005
    Article
18. The emerging role of the PI3-K-Akt pathway in prostate cancer progression.Prostate cancer and prostatic diseases · 2005
    Review
19. JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis.Leukemia · 2004
    Review
20. Specificity in the activation and control of transcription factor E2F-dependent apoptosis.Proceedings of the National Academy of Sciences of the United States of America · 2003
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

Abstract

Indexed as